Welcome to our dedicated page for INSPIRE VETERINARY PARTNERS SEC filings (Ticker: IVP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on INSPIRE VETERINARY PARTNERS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into INSPIRE VETERINARY PARTNERS's regulatory disclosures and financial reporting.
Inspire Veterinary Partners (Nasdaq: IVP) filed an 8-K disclosing two capital-raising arrangements that could supply up to $60 million of new funding but introduce meaningful dilution.
On 28-29 Jul 2025 the company signed a Securities Purchase Agreement for a private placement of up to 7,590 Series B convertible preferred shares (stated value $1,000) plus equal-number warrants. At the first closing investors bought 6,340 preferred shares and 6,340,000 five-year warrants for $5 million. The preferred converts at $1.00 per share (floor $0.1876) and the warrants initially exercise at $1.00, both subject to reset on lower-priced issuances. The stock ranks senior to all other equity, has no voting rights, and carries standard anti-dilution, redemption (125% premium) and change-of-control protections. The company must reserve 250 % of the shares needed for conversion and file a resale registration statement.
Separately, IVP entered a $50 million committed equity line with a single accredited investor. IVP may, at its option, sell up to $5 million of common stock per notice when the market price is ≥$0.75, subject to a 4.99 % ownership cap. Proceeds are earmarked for working capital. Either party can terminate under customary default, delisting or bankruptcy triggers.
- Aggregate potential raise: $60 million
- Immediate cash received: ~$5 million
- Maximum dilution: variable; conversion and warrant floors set at ~$0.19